Tomasz Olesiński

1.9k total citations
36 papers, 422 citations indexed

About

Tomasz Olesiński is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomasz Olesiński has authored 36 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Oncology, 18 papers in Surgery and 18 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomasz Olesiński's work include Gastric Cancer Management and Outcomes (15 papers), Colorectal Cancer Surgical Treatments (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Tomasz Olesiński is often cited by papers focused on Gastric Cancer Management and Outcomes (15 papers), Colorectal Cancer Surgical Treatments (6 papers) and Pancreatic and Hepatic Oncology Research (6 papers). Tomasz Olesiński collaborates with scholars based in Poland, United States and Italy. Tomasz Olesiński's co-authors include Kohei Shitara, Mustafa Özgüroğlu, Hyun Cheol Chung, Mario Mandalà, Kei Muro, Min‐Hee Ryu, Maria Di Bartolomeo, Chie‐Schin Shih, Charles S. Fuchs and Yung‐Jue Bang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Scientific Reports.

In The Last Decade

Tomasz Olesiński

30 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomasz Olesiński Poland 12 232 194 144 100 82 36 422
Maria Rosaria Diadema Italy 8 273 1.2× 188 1.0× 105 0.7× 68 0.7× 54 0.7× 10 406
S-E. Al-Batran Germany 10 220 0.9× 302 1.6× 179 1.2× 59 0.6× 53 0.6× 21 487
Zhenbin Shen China 14 168 0.7× 200 1.0× 105 0.7× 123 1.2× 96 1.2× 25 428
Adrian Goldiș Romania 11 146 0.6× 157 0.8× 110 0.8× 133 1.3× 91 1.1× 27 408
Margherita Pinto Italy 8 338 1.5× 308 1.6× 178 1.2× 153 1.5× 45 0.5× 10 566
Keita Uchino Japan 12 215 0.9× 151 0.8× 59 0.4× 86 0.9× 39 0.5× 40 357
Da-zhi Xu China 9 175 0.8× 293 1.5× 163 1.1× 154 1.5× 76 0.9× 12 528
Takuo Takehana Japan 7 338 1.5× 224 1.2× 81 0.6× 140 1.4× 43 0.5× 14 478
Sabina Murgioni Italy 11 214 0.9× 145 0.7× 85 0.6× 73 0.7× 76 0.9× 38 361

Countries citing papers authored by Tomasz Olesiński

Since Specialization
Citations

This map shows the geographic impact of Tomasz Olesiński's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomasz Olesiński with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomasz Olesiński more than expected).

Fields of papers citing papers by Tomasz Olesiński

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomasz Olesiński. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomasz Olesiński. The network helps show where Tomasz Olesiński may publish in the future.

Co-authorship network of co-authors of Tomasz Olesiński

This figure shows the co-authorship network connecting the top 25 collaborators of Tomasz Olesiński. A scholar is included among the top collaborators of Tomasz Olesiński based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomasz Olesiński. Tomasz Olesiński is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kotowicz, Beata, Mariola Winiarek, Małgorzata Fuksiewicz, et al.. (2024). Interleukin-6 as a Predictive Factor of Pathological Response to FLOT Regimen Systemic Treatment in Locally Advanced Gastroesophageal Junction or Gastric Cancer Patients. Cancers. 16(4). 757–757. 2 indexed citations
2.
Kaźmierczak, Wojciech, et al.. (2024). A common druggable signature of oncogenic c-Myc, mutant KRAS and mutant p53 reveals functional redundancy and competition among oncogenes in cancer. Cell Death and Disease. 15(8). 638–638. 7 indexed citations
3.
Żorniak, Michał, Paulina Wieszczy, Aleksandra Kapała, et al.. (2023). To push or to pull? A clinical audit on the efficacy and safety of the pull and push percutaneous endoscopic gastrostomy techniques in oncological patients. United European Gastroenterology Journal. 11(10). 951–959. 3 indexed citations
4.
Shitara, Kohei, Maria Di Bartolomeo, Mario Mandalà, et al.. (2023). Association between gene expression signatures and clinical outcomes of pembrolizumab versus paclitaxel in advanced gastric cancer: exploratory analysis from the randomized, controlled, phase III KEYNOTE-061 trial. Journal for ImmunoTherapy of Cancer. 11(6). e006920–e006920. 19 indexed citations
5.
Pietrzak, Lucyna, Wojciech Michalski, Andrzej Rutkowski, et al.. (2023). Which tumour factors preclude organ preservation in patients with rectal cancer?. Radiotherapy and Oncology. 191. 110054–110054. 2 indexed citations
6.
Winiarek, Mariola, Jakub Pałucki, Paulina Wieszczy, et al.. (2022). Safety and efficacy of the FLOT regimen in the Polish population - an analysis of the prospective trial. Neoplasma. 69(6). 1445–1450.
7.
Jastrzębski, Kamil, Wojciech Kaźmierczak, Tomasz Olesiński, et al.. (2022). The molecular network of the proteasome machinery inhibition response is orchestrated by HSP70, revealing vulnerabilities in cancer cells. Cell Reports. 40(13). 111428–111428. 15 indexed citations
8.
Hennig, Ewa E., Anna Kluska, Magdalena Piątkowska, et al.. (2021). GWAS Links New Variant in Long Non-Coding RNA LINC02006 with Colorectal Cancer Susceptibility. Biology. 10(6). 465–465. 4 indexed citations
9.
Jankowski, Michał, Andrzej Rutkowski, Wojciech Zegarski, et al.. (2021). The surgical treatment of rectal cancer in Poland. The findings of a multi-center observational study by the Polish Society of Surgical Oncology (PSSO-01). SHILAP Revista de lepidopterología. 71(5). 282–289. 2 indexed citations
10.
Fuchs, Charles S., Mustafa Özgüroğlu, Yung‐Jue Bang, et al.. (2021). Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial. Gastric Cancer. 25(1). 197–206. 112 indexed citations
11.
Fuchs, Charles S., Mustafa Özgüroğlu, Yung‐Jue Bang, et al.. (2020). The association of molecular biomarkers with efficacy of pembrolizumab versus paclitaxel in patients with gastric cancer (GC) from KEYNOTE-061.. Journal of Clinical Oncology. 38(15_suppl). 4512–4512. 22 indexed citations
12.
Rutkowski, Andrzej, Lucyna Pietrzak, J Kryński, et al.. (2018). The gentamicin-collagen implant and the risk of distant metastases of rectal cancer following short-course radiotherapy and curative resection: the long-term outcomes of a randomized study. International Journal of Colorectal Disease. 33(8). 1087–1096. 2 indexed citations
13.
Bednarczyk, M., Tomasz Maj, Leszek Zając, et al.. (2018). Metastatic tumors of pancreas — whether and when surgical intervention is gainful for diseased people. Retrospective analysis of data from three surgery centers. Nowotwory Journal of Oncology. 68. 240–244. 1 indexed citations
14.
Rutkowski, Andrzej, et al.. (2018). Diagnostics and treatment of small intestine tumors in our own experience. Nowotwory Journal of Oncology. 68(4). 167–172.
15.
Olesiński, Tomasz, Małgorzata Malinowska, M. Zwierko, et al.. (2018). Conventional cytology vs. immunocytochemistry of intraoperative peritoneal washes in gastric cancer patients subjected to gastrectomy: clinical correlates and association with overall survival. Minerva Surgery. 73(3). 261–268. 1 indexed citations
16.
Shitara, Kohei, Mustafa Özgüroğlu, Yung‐Jue Bang, et al.. (2018). KEYNOTE-061: Phase 3 study of pembrolizumab vs paclitaxel for previously treated advanced gastric or gastroesophageal junction (G/GEJ) cancer. Annals of Oncology. 29. v123–v123. 14 indexed citations
17.
Krawczyk, Paweł, et al.. (2017). Evaluation of miR-506 and miR-4316 expression in early and non-invasive diagnosis of colorectal cancer. International Journal of Colorectal Disease. 32(7). 1057–1060. 47 indexed citations
18.
19.
Olesiński, Tomasz, et al.. (2017). Pancreatic Metastases of Rectal Cancer—Case Report and Literature Review. Journal of Gastrointestinal Cancer. 50(2). 338–341. 3 indexed citations
20.
Rutkowski, Andrzej, Leszek Zając, Lucyna Pietrzak, et al.. (2014). Surgical site infections following short-term radiotherapy and total mesorectal excision: results of a randomized study examining the role of gentamicin collagen implant in rectal cancer surgery. Techniques in Coloproctology. 18(10). 921–928. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Rosaria Diadema Breakdown of academic impact, for papers by S-E. Al-Batran Breakdown of academic impact, for papers by Zhenbin Shen Breakdown of academic impact, for papers by Adrian Goldiș Breakdown of academic impact, for papers by Margherita Pinto Breakdown of academic impact, for papers by Keita Uchino Breakdown of academic impact, for papers by Da-zhi Xu Breakdown of academic impact, for papers by Takuo Takehana Breakdown of academic impact, for papers by Sabina Murgioni
Rankless by CCL
2026